A New ELISA to Overcome the Pitfalls in Quantification of Recombinant Human Monoclonal Anti-HBs, GC1102, by Commercial Immunoassays

about

A New ELISA to Overcome the Pitfalls in Quantification of Recombinant Human Monoclonal Anti-HBs, GC1102, by Commercial Immunoassays

Item

http://www.wikidata.org/entity/Q57067984

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

A New ELISA to Overcome the Pi ...... 02, by Commercial Immunoassays

@en

A New ELISA to Overcome the Pi ...... 02, by Commercial Immunoassays

@nl

type

Item

label

A New ELISA to Overcome the Pi ...... 02, by Commercial Immunoassays

@en

A New ELISA to Overcome the Pi ...... 02, by Commercial Immunoassays

@nl

prefLabel

A New ELISA to Overcome the Pi ...... 02, by Commercial Immunoassays

@en

A New ELISA to Overcome the Pi ...... 02, by Commercial Immunoassays

@nl

P1476

A New ELISA to Overcome the Pi ...... 02, by Commercial Immunoassays

@en

P2093

Dong-Hyung Cho

http://www.w3.org/2001/XMLSchema#string

Gi Won Song

http://www.w3.org/2001/XMLSchema#string

Se-Ho Kim

http://www.w3.org/2001/XMLSchema#string

Yong Won Shin

http://www.w3.org/2001/XMLSchema#string

P2860

Passive immunity in prevention and treatment of infectious diseases

Selection and characterization of human antibodies against hepatitis B virus surface antigen (HBsAg) by phage-display.

Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen.

Targeting membrane proteins for antibody discovery using phage display.

Development and validation of an ELISA at acidic pH for the quantitative determination of IL-13 in human plasma and serum.

Poor sensitivity of rapid tests for the detection of antibodies to the hepatitis B virus: implications for field studies.

Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.

Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy.

Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg).

Comparison of the Abbott Architect i2000 assay, the Roche Modular Analytics E170 assay, and an immunoradiometric assay for serum hepatitis B virus markers.

P2888

s12575-018-0083-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12575-018-0083-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107280402

http://www.w3.org/2001/XMLSchema#string

P698

30275774

http://www.w3.org/2001/XMLSchema#string

P932

6158867

http://www.w3.org/2001/XMLSchema#string